The Wayback Machine - http://web.archive.org/web/20250201235055/https://finance.yahoo.com/sectors/healthcare/
Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
6.738T
Market Weight
9.86%
Industries
11
Companies
1211
Healthcare S&P 500 ^GSPC
Loading Chart for Healthcare
DELL

Day Return

Sector
0.20%
S&P 500
0.50%

YTD Return

Sector
6.69%
S&P 500
2.26%

1-Year Return

Sector
3.48%
S&P 500
22.65%

3-Year Return

Sector
6.60%
S&P 500
36.30%

5-Year Return

Sector
50.34%
S&P 500
85.92%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightYTD Return
All Industries
100.00%
6.69%
Drug Manufacturers - General
33.40%
4.45%
Medical Devices
13.56%
10.72%
Healthcare Plans
12.44%
8.97%
Diagnostics & Research
11.07%
6.48%
Biotechnology
10.75%
3.45%
Medical Instruments & Supplies
8.08%
7.48%
Medical Care Facilities
2.97%
9.97%
Drug Manufacturers - Specialty & Generic
2.66%
5.67%
Medical Distribution
2.51%
7.43%
Health Information Services
2.43%
15.08%
Pharmaceutical Retailers
0.14%
9.51%

Note: Percentage % data on heatmap indicates Day Return

Largest Companies in This Sector

View More
Table View
Heatmap View
Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
811.08 972.77 11.03% 729.417B -1.48% +5.06%
Buy
542.49 637.24 7.55% 499.245B -0.56% +7.24%
Strong Buy
152.15 168.45 5.54% 366.319B -0.47% +5.21%
Buy
183.90 203.34 4.92% 324.977B +4.70% +3.49%
Buy
98.82 123.97 3.78% 249.979B -0.13% -0.66%
Buy
597.75 660.39 3.46% 228.639B -1.48% +14.90%
Buy
127.93 133.08 3.36% 221.889B -0.68% +13.10%
Buy
571.88 629.37 3.08% 203.692B -1.43% +9.56%
Buy
222.74 269.50 2.43% 160.88B -0.15% -2.97%
Buy
285.42 316.05 2.32% 153.423B +0.49% +9.51%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
146.87 36.396B 0.09% +6.76%
270.77 18.975B 0.10% +6.73%
138.66 6.463B 0.45% +4.88%
92.67 6.369B 0.35% +2.90%
63.81 4.4B 0.40% +9.36%

Mutual Fund Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
193.78 40.511B 0.30% +6.26%
81.70 40.511B 0.30% +6.26%
135.48 18.975B 0.10% +6.77%
84.67 13.014B 0.80% +6.22%
84.46 13.014B 0.80% +6.20%

Healthcare Research

View More

Discover the Latest Analyst and Technical Research for This Sector

  • Analyst Report: Novartis AG

    Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

    Rating
    Price Target
     
  • Analyst Report: ResMed Inc.

    ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

    Rating
    Price Target
     
  • Analyst Report: Cardinal Health, Inc.

    Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

    Rating
    Price Target
     
  • Analyst Report: Revvity, Inc.

    Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

    Rating
    Price Target
     

From the Community

Healthcare News